0001104659-24-077831.txt : 20240703
0001104659-24-077831.hdr.sgml : 20240703
20240703171543
ACCESSION NUMBER: 0001104659-24-077831
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231117
FILED AS OF DATE: 20240703
DATE AS OF CHANGE: 20240703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bruck Claudine
CENTRAL INDEX KEY: 0001733680
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39202
FILM NUMBER: 241100922
MAIL ADDRESS:
STREET 1: 4995 BRADENTON AVE, SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017-3552
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Annovis Bio, Inc.
CENTRAL INDEX KEY: 0001477845
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 262540421
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 LINDENWOOD DRIVE, SUITE 225
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 484-875-3192
MAIL ADDRESS:
STREET 1: 101 LINDENWOOD DRIVE, SUITE 225
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: QR Pharma, Inc.
DATE OF NAME CHANGE: 20091202
4
1
tm2417696-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-11-17
0
0001477845
Annovis Bio, Inc.
ANVS
0001733680
Bruck Claudine
C/O ANNOVIS BIO, INC.
101 LINDENWOOD DR, SUITE 225
MALVERN
PA
19355
1
0
0
0
0
Stock Option (right to buy)
6.07
2023-11-17
4
A
0
26200
0
A
2033-11-17
Common Stock
26200
26200
D
On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved.
The stock option shall vest immediately upon grant date.
/s/ Maria Maccecchini Attorney-in-Fact
2024-07-03